Informed by prevalence rates from epidemiological and molecular imaging data we project that common variants distributed outside of the APOE region may account for approximately 23% of variation in liability for biological AD (Alpha+ and Tau+). The gene discussed is MAPT; the disease is Alzheimer disease.